SCHEMBL7569993

SCHEMBL7569993

Nc1cc(C(=O)O)c2ccccc2c1C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.48
HPGD P15428 2/20 0.47
HSD17B10 Q99714 2/20 0.47
CYP2C9 P11712 1/20 0.47
TSHR P16473 1/20 0.47
ALOX12 P18054 1/20 0.47
ATIC P31939 1/20 0.47
KDM4E B2RXH2 5/20 0.47
KMT2A Q03164 5/20 0.47
MEN1 O00255 4/20 0.47
ALDH1A1 P00352 3/20 0.47
CYP1A2 P05177 1/20 0.47
GLA P06280 1/20 0.47
CYP2C19 P33261 1/20 0.47
WDR5 P61964 1/20 0.44
THRB P10828 3/20 0.44
RXFP1 Q9HBX9 2/20 0.44
USP2 O75604 2/20 0.44
MAPT P10636 2/20 0.44
PKM P14618 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29860911 1.00 IDO1 (0.48) IDO1HPGDHSD17B10CYP2C9TSHR
SCHEMBL10940566 0.85 IDO1 (0.48) IDO1HPGDHSD17B10CYP2C9TSHR
SCHEMBL6006241 0.82 IDO1 (0.50) IDO1HPGDHSD17B10CYP2C9TSHR
SCHEMBL29511 0.82 HPGD (0.57) HPGDHSD17B10CYP2C9TSHRALOX12
SCHEMBL31401764 0.82 HPGD (0.57) HPGDHSD17B10CYP2C9TSHRALOX12
SCHEMBL32664881 0.82 KDM4E (0.42) IDO1HPGDHSD17B10CYP2C9KDM4E
SCHEMBL29417867 0.82 HPGD (0.57) HPGDHSD17B10CYP2C9TSHRALOX12
SCHEMBL6036418 0.81 HSD17B10 (0.61) IDO1HPGDHSD17B10CYP2C9TSHR
SCHEMBL27492829 0.80 GRM6 (0.42) IDO1HPGDHSD17B10CYP2C9TSHR
SCHEMBL6036108 0.79 IDO1 (0.47) IDO1HPGDHSD17B10CYP2C9TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250276300-A1 REDUCTION OF MONOMERIC ISOCYANATES BY POROUS MATERIAL BASF SE (DE) 2025-09-04 US disclosed
EP-4291588-B1 REDUCTION OF MONOMERIC ISOCYANATES BY POROUS MATERIAL BASF SE (DE) 2025-08-20 EP disclosed
EP-4291588-A1 REDUCTION OF MONOMERIC ISOCYANATES BY POROUS MATERIAL BASF SE (DE) 2023-12-20 EP disclosed
CN-116829611-A Reduction of monomeric isocyanates by porous materials 巴斯夫欧洲公司 2023-09-29 CN disclosed
US-20020094993-A1 Compositions for repelling crawling insects S.C. JOHNSON & SON, INC. 2002-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020094993-A1 Compositions for repelling crawling insects ACHE, DDT, GAP43 IDO1 2046/4885HPGD 3530/4885HSD17B10 1952/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.